Lv1
70 积分 2025-11-13 加入
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
A systematic review of economic evaluations of pharmacist services
2个月前
已关闭
ASHP National Survey of Pharmacy Practice in Hospital Settings: Clinical Services and Workforce-2024
2个月前
已完结
全球临床药学人工智能应用现状、中国路径及变革挑战
2个月前
已完结
Endocrine Manifestations and New Developments in Mitochondrial Disease
3个月前
已完结
Kidney Effects of Finerenone Added to Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
3个月前
已完结
Adding Finerenone to SGLT2 Inhibitors and Long-Term Kidney Outcomes in Diabetic Kidney Disease
3个月前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
3个月前
已完结
Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice
3个月前
已完结
Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
3个月前
已完结
皖公网安备34019202002308
